Covered recipient · General Payments record
MICHAEL NAGUIT
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2024
$5,117.73
- Reported across 277 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $624.66 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $297.23 | 12 |
| Janssen Pharmaceuticals, Inc | $125.93 | 1 |
| Neurocrine BioSciences, Inc. | $93.85 | 4 |
| Corium, Inc. | $46.84 | 4 |
| Teva Pharmaceuticals USA, Inc. | $37.73 | 2 |
| Axsome Therapeutics, Inc. | $23.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.21 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105093879 | CMS |
| ABBVIE INC. | $23.91 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105093881 | CMS |
| ABBVIE INC. | $19.47 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105093883 | CMS |
| ABBVIE INC. | $124.47 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105093885 | CMS |
| ABBVIE INC. | $27.15 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105093887 | CMS |
| ABBVIE INC. | $3.97 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105093889 | CMS |
| ABBVIE INC. | $15.08 | 08/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105093891 | CMS |
| ABBVIE INC. | $2.91 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105093893 | CMS |
| ABBVIE INC. | $27.92 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105093895 | CMS |
| ABBVIE INC. | $13.30 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105093897 | CMS |
| ABBVIE INC. | $28.26 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105093899 | CMS |
| ABBVIE INC. | $5.58 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105093901 | CMS |
| Axsome Therapeutics, Inc. | $23.08 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148305138 | CMS |
| Corium, LLC | $17.55 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100105431 | CMS |
| Corium, LLC | $8.00 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100126598 | CMS |
| Corium, LLC | $9.98 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100122940 | CMS |
| Corium, LLC | $11.31 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100120566 | CMS |
| Janssen Pharmaceuticals, Inc | $125.93 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078147431 | CMS |
| Neurocrine Biosciences, Inc. | $24.72 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150840728 | CMS |
| Neurocrine Biosciences, Inc. | $25.51 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150838490 | CMS |
| Neurocrine Biosciences, Inc. | $30.12 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150825728 | CMS |
| Neurocrine Biosciences, Inc. | $13.50 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150878605 | CMS |
| Teva Pharmaceuticals USA, Inc. | $21.40 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151726599 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.33 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151726641 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.